News & Press Releases

Behavioral Diagnostics Awarded Grant to Commercialize a Precision Medicine Test for Guiding Smoking Therapy

August 2016: Behavioral Diagnostics (BD) LLC is pleased to announce that the National Institutes of Health has awarded it the first installment of a $900,000 project to develop a quantitative test for smoking that uses saliva DNA.

Behavioral Diagnostics Awarded Grant to Commercialize Epigenetic Alcohol Test

May 2016: Behavioral Diagnostics Inc. (BDI) is pleased to announce that the National Institutes of Health has awarded it a $1.4 million grant to complete the initial commercialization of an epigenetic test for the detection of heavy alcohol consumption.

Co-founders of Cardio Diagnostics discuss their new technology

Dr. Meesha Dogan and Dr. Rob Philibert talk about their companies, what it takes to be a good CEO, what they are working on, and the advances in research technology.